Special Envoy Statement on GSK malaria announcement & BBC Interview
Click Here for BBC Interview
For Immediate Release:
January 21, 2010
United Nations –
"GlaxoSmithKline’s plan to publicly release exclusive data on over 13,500 compounds with malaria fighting capabilities is an invaluable gift to the scientific community and malaria victims at large. Allowing broad-based access to this important data will undoubtedly catalyze research and development and ensure a competitive marketplace that will ultimately make more interventions accessible to people who need them most. With a child dying every 30 seconds of malaria, accelerating innovation at this rate will directly translate into more lives saved.
In the effort to combat malaria, GlaxoSmithKline has created a revolutionary nexus between the corporate and humanitarian worlds. With just one year remaining until the Secretary-General’s deadline to ensure universal access to malaria control interventions, I’m extremely grateful for GlaxoSmithKline’s commitment."
Raymond G. Chambers
The Secretary-General’s Special Envoy
for Malaria